Literature DB >> 9680139

Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease.

L C Spender1, T Hussell, P J Openshaw.   

Abstract

Respiratory syncytial virus (RSV) is a frequent cause of severe lung disease in young children. Primed T cells are required for virus clearance, but are causally implicated in the enhanced pathology seen following RSV infection of some infants and experimental animals vaccinated against the virus. In BALB/c mice, vaccination with recombinant vaccinia virus expressing the viral attachment protein (G) leads to pulmonary eosinophilia during subsequent infection, which indirect evidence suggests may be due to CD4+ Th2 cells. The production of IFN-gamma, IL-2, -4, -5 and -10 cytokine mRNA by RT-PCR and intracellular cytokines by flow cytometry following RSV challenge of vaccinated mice were therefore compared. Lung eosinophilia was associated with enhanced local recruitment of CD4+ cells in G sensitized mice, while CD8+ cells dominated in mice vaccinated with the viral fusion protein (F) or second matrix protein (M2). Lung eosinophilia was also associated with a localized reduction in IFN-gamma and increased IL-4 and IL-5 mRNA transcription as well as elevated RSV specific IgG1 antibody production. Th2 cytokine protein production by T cells showed no apparent change. Although IFN-gamma production diminished in eosinophilic mice, it remained the major cytokine found in lung T cells. It was concluded that lung eosinophilia can develop despite abundant IFN-gamma production by local T cells, but is associated with a shift in the balance between Th2 and Th1 cytokine production.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9680139     DOI: 10.1099/0022-1317-79-7-1751

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  22 in total

1.  Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.

Authors:  P Steigerwald-Mullen; M G Kurilla; T J Braciale
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Mast cell-induced lung injury in mice infected with H5N1 influenza virus.

Authors:  Yanxin Hu; Yi Jin; Deping Han; Guozhong Zhang; Shanping Cao; Jingjing Xie; Jia Xue; Yi Li; Di Meng; Xiaoxu Fan; Lun-Quan Sun; Ming Wang
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

3.  Immunomodulation with IL-4R alpha antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease.

Authors:  Michael J Ripple; Dahui You; Srinivasa Honnegowda; Joseph D Giaimo; Andrew B Sewell; David M Becnel; Stephania A Cormier
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

4.  IFNgamma-producing, virus-specific CD8+ effector cells acquire the ability to produce IL-10 as a result of entry into the infected lung environment.

Authors:  Ellen M Palmer; Beth C Holbrook; Subhashini Arimilli; Griffith D Parks; Martha A Alexander-Miller
Journal:  Virology       Date:  2010-09-01       Impact factor: 3.616

5.  Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus.

Authors:  Nicholas W Lukacs; Martin L Moore; Brian D Rudd; Aaron A Berlin; Robert D Collins; Sandra J Olson; Samuel B Ho; R Stokes Peebles
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

6.  Modulation of protective immunity, eosinophilia, and cytokine responses by selective mutagenesis of a recombinant G protein vaccine against respiratory syncytial virus.

Authors:  Yan Huang; Robert Anderson
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

7.  Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice.

Authors:  R A Tripp; D Moore; L Jones; W Sullender; J Winter; L J Anderson
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

8.  Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge.

Authors:  G P Bembridge; J A Lopez; R Bustos; J A Melero; R Cook; H Mason; G Taylor
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

9.  C5 modulates airway hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expression.

Authors:  Guillermina A Melendi; Scott J Hoffman; Ruth A Karron; Pablo M Irusta; Federico R Laham; Alison Humbles; Brian Schofield; Chien-Hsiung Pan; Richard Rabold; Bhagvanji Thumar; Adeep Thumar; Norma P Gerard; Wayne Mitzner; Scott R Barnum; Craig Gerard; Steven R Kleeberger; Fernando P Polack
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  Virally delivered cytokines alter the immune response to future lung infections.

Authors:  James Harker; Alexander Bukreyev; Peter L Collins; Belinda Wang; Peter J M Openshaw; John S Tregoning
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.